A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer&#39;s Disease.

Posiphen (buntanetap) - Annovis Bio

http://www.ncbi.nlm.nih.gov/pubmed/38970127

Archana Balasubramanian; Brendan P Lucey; Donald Elbert; Douglas Galasko; Howard H Feldman; Jeremiah Momper; Judy Pa; Lawrence S Honig; Maria Maccecchini; Martin R Farlow; Randall Bateman; Robert A Rissman; Ronald G Thomas; Tim West; Vahan Aslanyan

Jul 6, 2024